These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 27461670)

  • 41. Low RASSF6 expression in pancreatic ductal adenocarcinoma is associated with poor survival.
    Ye HL; Li DD; Lin Q; Zhou Y; Zhou QB; Zeng B; Fu ZQ; Gao WC; Liu YM; Chen RW; Li ZH; Chen RF
    World J Gastroenterol; 2015 Jun; 21(21):6621-30. PubMed ID: 26074700
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Clinical implication of Sox9 and activated Akt expression in pancreatic ductal adenocarcinoma.
    Xia S; Feng Z; Qi X; Yin Y; Jin J; Wu Y; Wu H; Feng Y; Tao M
    Med Oncol; 2015 Jan; 32(1):358. PubMed ID: 25428381
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Expression of long non-coding RNA LOC285194 and its prognostic significance in human pancreatic ductal adenocarcinoma.
    Ding YC; Yu W; Ma C; Wang Q; Huang CS; Huang T
    Int J Clin Exp Pathol; 2014; 7(11):8065-70. PubMed ID: 25550852
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Correlation of laminin subunit alpha 3 expression in pancreatic ductal adenocarcinoma with tumor liver metastasis and survival.
    Xing Y; Jing X; Qing G; Jiang Y
    Radiol Oncol; 2024 Jun; 58(2):234-242. PubMed ID: 38452390
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Low expression of IGFBP7 is associated with poor outcome of pancreatic ductal adenocarcinoma.
    An W; Ben QW; Chen HT; Zheng JM; Huang L; Li GX; Li ZS
    Ann Surg Oncol; 2012 Nov; 19(12):3971-8. PubMed ID: 22622471
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Clinicopathological and prognostic significance of myofibrillogenesis regulator-1 protein expression in pancreatic ductal adenocarcinoma.
    Zhao CY; Guo ZJ; Dai SM; Zhang Y; Zhou JJ
    Tumour Biol; 2013 Oct; 34(5):2983-7. PubMed ID: 23696030
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Expression of vasohibin-2 in pancreatic ductal adenocarcinoma promotes tumor progression and is associated with a poor clinical outcome.
    Kim JC; Kim KT; Park JT; Kim HJ; Sato Y; Kim HS
    Hepatogastroenterology; 2015; 62(138):251-6. PubMed ID: 25916042
    [TBL] [Abstract][Full Text] [Related]  

  • 48. AQP1 and AQP3 Expression are Associated With Severe Symptoms and Poor-prognosis of the Pancreatic Ductal Adenocarcinoma.
    Zou W; Yang Z; Li D; Liu Z; Zou Q; Yuan Y
    Appl Immunohistochem Mol Morphol; 2019 Jan; 27(1):40-47. PubMed ID: 30531392
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Overexpressed EDIL3 predicts poor prognosis and promotes anchorage-independent tumor growth in human pancreatic cancer.
    Jiang SH; Wang Y; Yang JY; Li J; Feng MX; Wang YH; Yang XM; He P; Tian GA; Zhang XX; Li Q; Cao XY; Huo YM; Yang MW; Fu XL; Li J; Liu DJ; Dai M; Wen SY; Gu JR; Hong J; Hua R; Zhang ZG; Sun YW
    Oncotarget; 2016 Jan; 7(4):4226-40. PubMed ID: 26735172
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Increased expression of valosin-containing protein (p97) is associated with lymph node metastasis and prognosis of pancreatic ductal adenocarcinoma.
    Yamamoto S; Tomita Y; Hoshida Y; Nagano H; Dono K; Umeshita K; Sakon M; Ishikawa O; Ohigashi H; Nakamori S; Monden M; Aozasa K
    Ann Surg Oncol; 2004 Feb; 11(2):165-72. PubMed ID: 14761919
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Expression and clinical significance of Tspan 1 and Integrin α6 in human pancreatic ductal adenocarcinoma].
    Shi G; Dong M; Sheng W; Zhou J; Yu D; Sun W
    Zhonghua Wai Ke Za Zhi; 2014 Oct; 52(10):781-6. PubMed ID: 25573220
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Reduced expression of desmocollin 2 is an independent prognostic biomarker for shorter patients survival in pancreatic ductal adenocarcinoma.
    Hamidov Z; Altendorf-Hofmann A; Chen Y; Settmacher U; Petersen I; Knösel T
    J Clin Pathol; 2011 Nov; 64(11):990-4. PubMed ID: 21725043
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Decreased circadian component Bmal1 predicts tumor progression and poor prognosis in human pancreatic ductal adenocarcinoma.
    Li W; Liu L; Liu D; Jin S; Yang Y; Tang W; Gong L
    Biochem Biophys Res Commun; 2016 Mar; 472(1):156-62. PubMed ID: 26915801
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Prognostic significance of XB130 expression in surgically resected pancreatic ductal adenocarcinoma.
    Zhang J; Jiang X; Zhang J
    World J Surg Oncol; 2014 Mar; 12():49. PubMed ID: 24581082
    [TBL] [Abstract][Full Text] [Related]  

  • 55. CSN6 expression is associated with pancreatic cancer progression and predicts poor prognosis.
    Shi J; Guan X; Zhan F; Liu C; Li Z; Yao Y; Wang B; Lou C; Zhang Y
    Cancer Biol Ther; 2019; 20(9):1290-1299. PubMed ID: 31311398
    [TBL] [Abstract][Full Text] [Related]  

  • 56. High ROR2 expression in tumor cells and stroma is correlated with poor prognosis in pancreatic ductal adenocarcinoma.
    Huang J; Fan X; Wang X; Lu Y; Zhu H; Wang W; Zhang S; Wang Z
    Sci Rep; 2015 Aug; 5():12991. PubMed ID: 26259918
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Expression of amphiregulin predicts poor outcome in patients with pancreatic ductal adenocarcinoma.
    Wang L; Wu H; Wang L; Lu J; Duan H; Liu X; Liang Z
    Diagn Pathol; 2016 Jul; 11(1):60. PubMed ID: 27391842
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Downregulation of RPL15 may predict poor survival and associate with tumor progression in pancreatic ductal adenocarcinoma.
    Yan TT; Fu XL; Li J; Bian YN; Liu DJ; Hua R; Ren LL; Li CT; Sun YW; Chen HY; Fang JY; Hong J
    Oncotarget; 2015 Nov; 6(35):37028-42. PubMed ID: 26498693
    [TBL] [Abstract][Full Text] [Related]  

  • 59. CXCR4--A Prognostic and Clinicopathological Biomarker for Pancreatic Ductal Adenocarcinoma: A Meta-Analysis.
    Krieg A; Riemer JC; Telan LA; Gabbert HE; Knoefel WT
    PLoS One; 2015; 10(6):e0130192. PubMed ID: 26091099
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Prognostic significance of maspin in pancreatic ductal adenocarcinoma: tissue microarray analysis of 223 surgically resected cases.
    Cao D; Zhang Q; Wu LS; Salaria SN; Winter JW; Hruban RH; Goggins MS; Abbruzzese JL; Maitra A; Ho L
    Mod Pathol; 2007 May; 20(5):570-8. PubMed ID: 17396143
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.